GMNC and Alzheimer disease: Recently, it was reported that genetic variants in the GMNC‐OSTN region on chromosome 3 (described in detail in this study) were associated both with smaller ventricles and with increased CSF levels of the AD biomarker P‐tau (Jansen et al, 2022).